MedTrace Logo

Post-Traumatic Brain Injury (Post-TBI) Fatigue and Its Treatment

NCT00233090 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2016-04-15

Study results available
· View outcomes & findings →

Summary

Randomized clinical trial of modafinil vs. placebo for treatment of fatigue after TBI.

Conditions

Interventions

DRUG

Modafinil

single dose of 200 mg. a day of modafinil for four weeks

DRUG

Placebo

daily dose of placebo for four weeks.

Sponsors & Collaborators

Principal Investigators

  • Wayne A Gordon, Ph.D. · Icahn School of Medicine at Mount Sinai

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00233090 on ClinicalTrials.gov